EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multiomic analysis reveals a key BCAT1 role in mTOR activation by B cell receptor and TLR9

Rui Guo, Yizhe Sun, Matthew Y Lim, Hardik Shah, Joao A Paulo, Rahaman A Ahmed, Weixing Li, Yuchen Zhang, Haopeng Yang, Liang Wei Wang, Daniel Strebinger, Nicholas A Smith und 15 weitere

Journal of Clinical Investigation · 17.11.2025 · 135 (22)

DOI: 10.1172/jci186258 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 09.09.2025. Verfasst von Rui Guo und 26 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Receptors, Antigen, B-Cell, Toll-Like Receptor 9, B-Lymphocytes, TOR Serine-Threonine Kinases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDCR NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

B lymphocytes play major adaptive immune roles, producing antibodies and driving T cell responses. However, how immunometabolism networks support B cell activation and differentiation in response to distinct receptor stimuli remains incompletely understood. To gain insights, we systematically investigated acute primary human B cell transcriptional, translational, and metabolomic responses to B cell receptor (BCR), TLR9, CD40-ligand (CD40L), IL-4, or combinations thereof. T cell–independent BCR/TLR9 costimulation, which drives malignant and autoimmune B cell states, highly induced transaminase branched chain amino acid transaminase 1 (BCAT1), which localized to lysosomal membranes to support branched chain amino acid synthesis and mTORC1 activation. BCAT1 inhibition blunted BCR/TLR9, but not CD40L/IL-4–triggered B cell proliferation, IL-10 expression, and BCR/TLR pathway–driven lymphoma xenograft outgrowth. These results provide a valuable resource, reveal receptor-mediated immunometabolism remodeling to support key B cell phenotypes, and identify BCAT1 as an activated B cell therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Antigen, B-CellToll-Like Receptor 9B-LymphocytesTOR Serine-Threonine KinasesTransaminasesHumansAnimalsMiceLymphocyte ActivationMechanistic Target of Rapamycin Complex 1Signal Transduction

Stichwörter der Autor:innen

Adaptive immunityAmino acid metabolismCell biologyLymphomasMetabolism

Substanzen

Receptors, Antigen, B-CellToll-Like Receptor 9TOR Serine-Threonine KinasesTLR9 protein, humanBCAT1 protein, humanTransaminasesMTOR protein, humanMechanistic Target of Rapamycin Complex 1

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Center for Integrated Solutions in Infectious Disease, Broad Institute, Cambridge, Massachusetts, USA.
  • Department of Microbiology and.
  • Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
  • Harvard Program in Virology, Boston, Massachusetts, USA.
  • Howard Hughes Medical Institute and Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts, USA.

Förderung

  • NCI NIH HHS
  • NIDCR NIH HHS
  • NIGMS NIH HHS
  • NIAID NIH HHS
  • National Institutes of Health
  • American Cancer Society
  • Swiss National Science Foundation

Zitieren

APA

Guo, R., Sun, Y., Lim, M. Y., Shah, H., Paulo, J. A., Ahmed, R. A., Li, W., Zhang, Y., Yang, H., Wang, L. W., Strebinger, D., Smith, N. A., Li, M., Leong, M. M. L., Lutchenkov, M., Liang, J. H., Li, Z., Wang, Y., Puri, R., …, & Gewurz, B. E. (2025). Multiomic analysis reveals a key BCAT1 role in mTOR activation by B cell receptor and TLR9. Journal of Clinical Investigation, 135(22). https://doi.org/10.1172/jci186258

Vancouver

Guo R, Sun Y, Lim MY, Shah H, Paulo JA, Ahmed RA, et al. Multiomic analysis reveals a key BCAT1 role in mTOR activation by B cell receptor and TLR9. Journal of Clinical Investigation. 2025;135(22). doi:10.1172/jci186258

BibTeX
@article{Guo2025,
  author = {Guo, Rui and Sun, Yizhe and Lim, Matthew Y and Shah, Hardik and Paulo, Joao A and Ahmed, Rahaman A and Li, Weixing and Zhang, Yuchen and Yang, Haopeng and Wang, Liang Wei and Strebinger, Daniel and Smith, Nicholas A and Li, Meng and Leong, Merrin Man Long and Lutchenkov, Michael and Liang, Jin Hua and Li, Zhixuan and Wang, Yin and Puri, Rishi and Melnick, Ari and Green, Michael R and Asara, John M and Papathanassiu, Adonia E and Wesemann, Duane R and Gygi, Steven P and Mootha, Vamsi K and Gewurz, Benjamin E},
  title = {Multiomic analysis reveals a key BCAT1 role in mTOR activation by B cell receptor and TLR9},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  volume = {135},
  number = {22},
  doi = {10.1172/jci186258}
}
Kostenlos starten →